Ariel Investments, an investment management company, released its “Ariel Focus Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund reported strong first-quarter ...
Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research. HERCULES, Calif.—May 05, 2025 ...
From data quality and AI readiness to the realities of clinical translation, industry leaders share where precision still ...
Zion Market Research has published a new research report titled “Blood Banking Devices Market By Product (Blood Processing ...
Arboretum Ventures, a health care venture capital firm based in Ann Arbor, has promoted Jeff Terrell to managing partner. ...
These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...
Stockhead on MSN
April ASX healthcare wrap: Sector falls 8.67pc as Cochlear tumbles, outperformers emerge
The S&P/ASX Healthcare Index fell 8.67% in April as Cochlear dropped 40% in its biggest ever daily fall on April ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results